Neurosteroidogenic enzymes: CYP11A1 in the central nervous system

Front Neuroendocrinol. 2021 Jul:62:100925. doi: 10.1016/j.yfrne.2021.100925. Epub 2021 May 18.

Abstract

Neurosteroids, steroid hormones synthesized locally in the nervous system, have important neuromodulatory and neuroprotective effects in the central nervous system. Progress in neurosteroid research has led to the successful translation of allopregnanolone into an approved therapy for postpartum depression. However, there is insufficient evidence to support the assumption that steroidogenesis is exactly the same between the nervous system and the periphery. This review focuses on CYP11A1, the only enzyme currently known to catalyze the first reaction in steroidogenesis to produce pregnenolone, the precursor to all other steroids. Although CYP11A1 mRNA has been found in brain of many mammals, the presence of CYP11A1 protein has been difficult to detect, particularly in humans. Here, we highlight the discrepancies in the current evidence for CYP11A1 in the central nervous system and propose new directions for understanding neurosteroidogenesis, which will be crucial for developing neurosteroid-based therapies for the future.

Keywords: Brain; CYP11A1; Central nervous system; Cytochrome P450; Neurosteroids; Pregnenolone; Retina; Spinal cord; Steroidogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain
  • Central Nervous System*
  • Cholesterol Side-Chain Cleavage Enzyme*
  • Female
  • Humans
  • Pregnanolone
  • Pregnenolone

Substances

  • Pregnenolone
  • Pregnanolone
  • Cholesterol Side-Chain Cleavage Enzyme